Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.
about
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
P2860
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of liver stiffness ...... ndergoing rituximab treatment.
@en
Assessment of liver stiffness ...... ndergoing rituximab treatment.
@nl
type
label
Assessment of liver stiffness ...... ndergoing rituximab treatment.
@en
Assessment of liver stiffness ...... ndergoing rituximab treatment.
@nl
prefLabel
Assessment of liver stiffness ...... ndergoing rituximab treatment.
@en
Assessment of liver stiffness ...... ndergoing rituximab treatment.
@nl
P2093
P2860
P50
P356
P1476
Assessment of liver stiffness ...... undergoing rituximab treatment
@en
P2093
Anna Linda Zignego
Antonio Petrarca
Elisa Triboli
Teresa Urraro
Umberto Arena
P2860
P2888
P356
10.1186/1479-5876-12-21
P577
2014-01-24T00:00:00Z
P5875
P6179
1016364266